Search Results 1591-1600 of 16958 for monoclonal antibody

1. Hematology - Clinical trials

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

2. Neurology - Clinical trials

   The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research ...

3. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   ... antibody therapy is allowed regardless of the prior treatment settings. For Phase II, Arms 1 and 2, prior cetuximab or other EGFR-targeted antibody ...

4. Mechanisms of Astrocyte Reactivity - Translational Neuroimmunology Laboratory - Mayo Clinic Research

   Focus areas include: Discovering the mechanisms underlying astrocyte reactivity induced by the pathogenic antibody present in patients with neuromyelitis optica ...

5. Meningococcal vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Meningococcal infection can cause life-threatening ...

6. Patient Stories - Laboratory Medicine and Pathology - Mayo Clinic

   Patient stories. Spencer_at_home16x9-1024x576.jpg. Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody. What started as ...

7. Intrathecally Administered Gene Therapy APB-102 in Rapidly Progressive ALS Patients with SOD1 Mutations - Mayo Clinic

   Titer for neutralizing antibodies (NAb) to AAV rh10 > [1:50] at Screening ... antibody (anti-HCV) or hepatitis B surface antigen (HBsAg); or who have ...

8. 7T MR Imaging in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) - Mayo Clinic

   Detection of clinically relevant donor-specific allo-Human Leukocyte Antigen (HLA) reactive antibodies ... Clinical diagnosis of autoimmune epilepsy, supported by ...

9. A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Serum monoclonal paraprotein (M-protein) level ≥1.0 g/dL or urine M-protein level ≥200 mg/24 hours; or; Light chain MM without measurable disease in serum ...

10. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... antibody (HBc Ab) positive subjects;; HCV: HCV ribonucleic acid (RNA) detectable in any subject positive with anti-HCV antibody (HCV Ab). Subject with a ...